Cell therapy holds immense promise for curing diseases, but a major roadblock stands in the way - manufacturing. Producing these life-saving treatments is complex and expensive, raising concerns about affordability and accessibility. This article dives into the manufacturing bottlenecks hindering cell therapy's widespread adoption. We'll explore challenges like: Scalability: Scaling up production to meet patient demand remains a significant hurdle...